Buscar
Mostrando ítems 1-7 de 7
HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
(Mediscript, 2020)
In this viewpoint we would like to describe our results in terms of resistance pattern in Chilean patients with virological failure (VF) on raltegravir (RAL)-containing-regimens and highlight the need for the concomitant ...
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Background: HIV-2 is a neglected virus despite estimates of 1-2 million people being infected worldwide. The virus is naturally resistant to some antiretrovirals used to treat HIV-1 and therapeutic options are limited for ...
Four-Dimensional Structure-Activity Relationship Model to Predict HIV-1 Integrase Strand Transfer Inhibition using LQTA-QSAR Methodology
(Amer Chemical SocWashingtonEUA, 2012)
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
(American Society for Microbiology, 2023)
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
(Massachusetts Medical Society, 2021)